Report Detail
Global (United States, European Union and China) Disease Control and Prevention Vaccine Market Research Report 2019-2025
- RnM3686038 |
- 20 August, 2019 |
- Global |
- 119 Pages |
- QYResearch |
- Pharma & Healthcare
Vaccines are biological entity used to activate acquired immunity to control or prevent particular disease or a group of disease. Immunization is carried out in infants as well as in adults. Vaccination against various bacterial and viral diseases is an integral part of infectious disease control world-wide.
In 2019, the market size of Disease Control and Prevention Vaccine is 41100 million US$ and it will reach 102500 million US$ in 2025, growing at a CAGR of 12.1% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Disease Control and Prevention Vaccine.
This report studies the global market size of Disease Control and Prevention Vaccine, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Disease Control and Prevention Vaccine sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
GSK
Merck & Co., Inc
Pfizer
Sanofi
AstraZeneca PLC
Sinovac Biotech Ltd
Astellas Pharma Inc
Serum Institute of India Pvt. Ltd
Daiichi Sankyo
Market Segment by Product Type
Live-Attenuated
Inactivated
Recombinant Sub Unit and Toxoid
Market Segment by Application
Pediatric Vaccine
Adult Vaccine
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Disease Control and Prevention Vaccine status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Disease Control and Prevention Vaccine manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Disease Control and Prevention Vaccine are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Disease Control and Prevention Vaccine Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Live-Attenuated
- 1.3.3 Inactivated
- 1.3.4 Recombinant Sub Unit and Toxoid
- 1.4 Market Segment by Application
- 1.4.1 Global Disease Control and Prevention Vaccine Market Share by Application (2019-2025)
- 1.4.2 Pediatric Vaccine
- 1.4.3 Adult Vaccine
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Disease Control and Prevention Vaccine Market Size
- 2.1.1 Global Disease Control and Prevention Vaccine Revenue 2014-2025
- 2.1.2 Global Disease Control and Prevention Vaccine Sales 2014-2025
- 2.2 Disease Control and Prevention Vaccine Growth Rate by Regions
- 2.2.1 Global Disease Control and Prevention Vaccine Sales by Regions 2014-2019
- 2.2.2 Global Disease Control and Prevention Vaccine Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Disease Control and Prevention Vaccine Sales by Manufacturers
- 3.1.1 Disease Control and Prevention Vaccine Sales by Manufacturers 2014-2019
- 3.1.2 Disease Control and Prevention Vaccine Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Disease Control and Prevention Vaccine Revenue by Manufacturers (2014-2019)
- 3.2.2 Disease Control and Prevention Vaccine Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Disease Control and Prevention Vaccine Market Concentration Ratio (CR5 and HHI)
- 3.3 Disease Control and Prevention Vaccine Price by Manufacturers
- 3.4 Key Manufacturers Disease Control and Prevention Vaccine Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Disease Control and Prevention Vaccine Market
- 3.6 Key Manufacturers Disease Control and Prevention Vaccine Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Live-Attenuated Sales and Revenue (2014-2019)
- 4.1.2 Inactivated Sales and Revenue (2014-2019)
- 4.1.3 Recombinant Sub Unit and Toxoid Sales and Revenue (2014-2019)
- 4.2 Global Disease Control and Prevention Vaccine Sales Market Share by Type
- 4.3 Global Disease Control and Prevention Vaccine Revenue Market Share by Type
- 4.4 Disease Control and Prevention Vaccine Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Disease Control and Prevention Vaccine Sales by Application
6 United States
- 6.1 United States Disease Control and Prevention Vaccine Breakdown Data by Company
- 6.2 United States Disease Control and Prevention Vaccine Breakdown Data by Type
- 6.3 United States Disease Control and Prevention Vaccine Breakdown Data by Application
7 European Union
- 7.1 European Union Disease Control and Prevention Vaccine Breakdown Data by Company
- 7.2 European Union Disease Control and Prevention Vaccine Breakdown Data by Type
- 7.3 European Union Disease Control and Prevention Vaccine Breakdown Data by Application
8 China
- 8.1 China Disease Control and Prevention Vaccine Breakdown Data by Company
- 8.2 China Disease Control and Prevention Vaccine Breakdown Data by Type
- 8.3 China Disease Control and Prevention Vaccine Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Disease Control and Prevention Vaccine Breakdown Data by Company
- 9.2 Rest of World Disease Control and Prevention Vaccine Breakdown Data by Type
- 9.3 Rest of World Disease Control and Prevention Vaccine Breakdown Data by Application
- 9.4 Rest of World Disease Control and Prevention Vaccine Breakdown Data by Countries
- 9.4.1 Rest of World Disease Control and Prevention Vaccine Sales by Countries
- 9.4.2 Rest of World Disease Control and Prevention Vaccine Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 GSK
- 10.1.1 GSK Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Disease Control and Prevention Vaccine
- 10.1.4 Disease Control and Prevention Vaccine Product Introduction
- 10.1.5 GSK Recent Development
- 10.2 Merck & Co., Inc
- 10.2.1 Merck & Co., Inc Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Disease Control and Prevention Vaccine
- 10.2.4 Disease Control and Prevention Vaccine Product Introduction
- 10.2.5 Merck & Co., Inc Recent Development
- 10.3 Pfizer
- 10.3.1 Pfizer Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Disease Control and Prevention Vaccine
- 10.3.4 Disease Control and Prevention Vaccine Product Introduction
- 10.3.5 Pfizer Recent Development
- 10.4 Sanofi
- 10.4.1 Sanofi Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Disease Control and Prevention Vaccine
- 10.4.4 Disease Control and Prevention Vaccine Product Introduction
- 10.4.5 Sanofi Recent Development
- 10.5 AstraZeneca PLC
- 10.5.1 AstraZeneca PLC Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Disease Control and Prevention Vaccine
- 10.5.4 Disease Control and Prevention Vaccine Product Introduction
- 10.5.5 AstraZeneca PLC Recent Development
- 10.6 Sinovac Biotech Ltd
- 10.6.1 Sinovac Biotech Ltd Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Disease Control and Prevention Vaccine
- 10.6.4 Disease Control and Prevention Vaccine Product Introduction
- 10.6.5 Sinovac Biotech Ltd Recent Development
- 10.7 Astellas Pharma Inc
- 10.7.1 Astellas Pharma Inc Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Disease Control and Prevention Vaccine
- 10.7.4 Disease Control and Prevention Vaccine Product Introduction
- 10.7.5 Astellas Pharma Inc Recent Development
- 10.8 Serum Institute of India Pvt. Ltd
- 10.8.1 Serum Institute of India Pvt. Ltd Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Disease Control and Prevention Vaccine
- 10.8.4 Disease Control and Prevention Vaccine Product Introduction
- 10.8.5 Serum Institute of India Pvt. Ltd Recent Development
- 10.9 Daiichi Sankyo
- 10.9.1 Daiichi Sankyo Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Disease Control and Prevention Vaccine
- 10.9.4 Disease Control and Prevention Vaccine Product Introduction
- 10.9.5 Daiichi Sankyo Recent Development
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Disease Control and Prevention Vaccine Sales Channels
- 11.2.2 Disease Control and Prevention Vaccine Distributors
- 11.3 Disease Control and Prevention Vaccine Customers
12 Market Forecast
- 12.1 Global Disease Control and Prevention Vaccine Sales and Revenue Forecast 2019-2025
- 12.2 Global Disease Control and Prevention Vaccine Sales Forecast by Type
- 12.3 Global Disease Control and Prevention Vaccine Sales Forecast by Application
- 12.4 Disease Control and Prevention Vaccine Forecast by Regions
- 12.4.1 Global Disease Control and Prevention Vaccine Sales Forecast by Regions 2019-2025
- 12.4.2 Global Disease Control and Prevention Vaccine Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Disease Control and Prevention Vaccine. Industry analysis & Market Report on Disease Control and Prevention Vaccine is a syndicated market report, published as Global (United States, European Union and China) Disease Control and Prevention Vaccine Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Disease Control and Prevention Vaccine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
